Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells Lena Avinery; Danielle Regev; Hazem Khamaisi; Jacob Gopas; Jamal Mahajna;

Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;

Obstetrical use of intravenous immunoglobulin: A single-centre retrospective study Roy Khalife; Bonnie Niu; Iris Perelman; Darine El-Chaâr; Dean Fergusson; Alan Karovitch; Johnathan Mack; Melanie Tokessy; Kathryn E. Webert; Alan Tinmouth;